Pharma Journalist -

The Lupus Research Alliance has welcomed the U.S. Food and Drug Administration’s decision to grant Breakthrough Therapy designation to litifilimab (BIIB059), an investigational…
Read More...

Sensorion, a clinical-stage biotechnology company focused on developing novel treatments to restore, treat, and prevent hearing loss, has announced a €60 million capital raise to…
Read More...

AstraZeneca has strengthened its weight management and metabolic disease pipeline through a new strategic collaboration with CSPC Pharmaceuticals, targeting the development of multiple…
Read More...

AstraZeneca has announced a landmark $15 billion investment in China through 2030, significantly expanding its research, development, and manufacturing capabilities as part of its…
Read More...

Repertoire® Immune Medicines, a biotechnology company focused on programmable T cell–targeted immune medicines, has entered into a major strategic collaboration with Eli Lilly and…
Read More...

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending conditional marketing authorisation for Rezurock…
Read More...

Otsuka Pharmaceutical Development & Commercialization, Inc., together with Otsuka Pharmaceutical Co., Ltd., has reached a key regulatory milestone after the U.S. Food and Drug…
Read More...

Simcere Pharmaceutical Group Ltd. and Boehringer Ingelheim have entered into a global license and collaboration agreement to develop SIM0709, a pre-clinical bispecific antibody designed…
Read More...

Insilico Medicine and Qilu Pharmaceutical Group have entered into a strategic partnership aimed at accelerating the discovery and development of new therapies for cardiometabolic…
Read More...

Mirum Pharmaceuticals, Inc. has completed its acquisition of Bluejay Therapeutics, a privately held biotechnology company focused on viral and liver diseases, marking a significant step…
Read More...